Literature DB >> 690445

H-2 linked Ir gene control of antibody responses to porcine insulin. I. Development of insulin-specific antibodies in some but not all nonresponder strains injected with proinsulin.

J A Kapp, D S Strayer.   

Abstract

Cell-mediated and humoral immune responses to heterologous insulins in mice are controlled by H-2 linked, dominant, immune response (Ir) genes. For example, mice bearing the H-2d haplotype develop T cell proliferative responses and produce antibody after injection with porcine insulin, whereas mice bearing other H-2 haplotypes do not. Data presented in this communication demonstrate that homozygous and heterozygous H-2d mice produce insulin-binding antibodies when immunized with porcine insulin or proinsulin. Some (H-2b,k,s) insulin-nonresponder mice produce insulin-binding antibodies after injection of proinsulin, whereas other insulin-nonresponder strains (H-2q) do not. All strains, except homozygous H-2q mice, produce antibodies specific for proinsulin, suggesting that the response to porcine proinsulin is also controlled by H-2-linked Ir genes. More importantly, F1 hybrids between insulin-nonresponder C57BL/10 (H-2b) and DBA/1 (H-2q) produce no insulin-binding antibodies when injected with proinsulin, despite the fact that proinsulin-binding antibodies are produced by these mice.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 690445

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Function of macrophages as antigen presenting cells.

Authors:  J Schroer; A S Rosenthal
Journal:  Springer Semin Immunopathol       Date:  1980-08

Review 2.  Insulin antibody determination: theoretical and practical considerations.

Authors:  W G Reeves
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

3.  HLA phenotype and insulin antibody production.

Authors:  W G Reeves; K Gelsthorpe; P Van der Minne; R Torensma; R B Tattersall
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

4.  Analysis of the in vitro immune response to insulin. I. Primary induction of insulin-specific T helper cells and characterization of the genetic control of the helper cell response to bovine and porcine insulin.

Authors:  P Erb
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

5.  Antigenicity of low molecular weight surfactant species.

Authors:  D S Strayer; T A Merritt; C Makunike; M Hallman
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

6.  Factors governing the human immune response to injected insulin.

Authors:  W G Reeves; D Barr; C A Douglas; K Gelsthorpe; I Hanning; A Skene; L Wells; R M Wilson; R B Tattersall
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

7.  The human cellular immune response to insulin: a study in unexposed control subjects and type I diabetic patients on acute and chronic treatment.

Authors:  E R Richens; M E Seward; W A Luqman; M Hartog
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

8.  In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.

Authors:  D L Mann; N Mendell; C R Kahn; A H Johnson; A Rosenthal
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

9.  The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model.

Authors:  J L Ottesen; P Nilsson; J Jami; D Weilguny; M Dührkop; D Bucchini; S Havelund; J M Fogh
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

10.  Tolerance induced by physiological levels of secreted proteins in transgenic mice expressing human insulin.

Authors:  P J Whiteley; J P Lake; R F Selden; J A Kapp
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.